A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
Clinical trial NCT05600036 · COMPLETED
Trial details
- NCT number
- NCT05600036
- Sponsor
- Alumis Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2023-06-29
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.